Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$859M |
| 2 |
Progressive
PGR
|
+$429M |
| 3 |
Netflix
NFLX
|
+$368M |
| 4 |
Danaher
DHR
|
+$364M |
| 5 |
Adobe
ADBE
|
+$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$710M |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
NVIDIA
NVDA
|
+$447M |
| 4 |
Eli Lilly
LLY
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Fair Isaac
FICO
$37.3B
| $3.11M | ﹤0.01% |
3,836
-8,099
| -68% | -$6.56M |
|
1027
Clorox
CLX
$15.2B
| $3.09M | ﹤0.01% |
19,428
-31,588
| -62% | -$5.02M |
|
1028
DXC Technology
DXC
$2.58B
| $3.09M | ﹤0.01% |
115,530
-140
| -0.1% | -$3.74K |
|
1029
Universal Display
OLED
$6.51B
| $3.08M | ﹤0.01% |
21,384
-25
| -0.1% | -$3.6K |
|
1030
ArcBest
ARCB
$1.63B
| $3.07M | ﹤0.01% |
31,066
+11,804
| +61% | +$1.17M |
|
1031
Stifel
SF
$11.8B
| $3.07M | ﹤0.01% |
51,418
-12,202
| -19% | -$728K |
|
1032
Olin
OLN
$3.06B
| $3.06M | ﹤0.01% |
59,490
-81,720
| -58% | -$4.2M |
|
|
SGEN
1033
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.04M | ﹤0.01% |
15,816
-1,236
| -7% | -$238K |
|
1034
AutoNation
AN
$8.45B
| $3.03M | ﹤0.01% |
18,385
-129
| -0.7% | -$21.2K |
|
1035
Fulgent Genetics
FLGT
$676M
| $3.01M | ﹤0.01% |
81,278
+20,780
| +34% | +$769K |
|
1036
Comerica
CMA
$8.95B
| $3.01M | ﹤0.01% |
71,019
-67
| -0.1% | -$2.84K |
|
1037
Navient
NAVI
$1.29B
| $3.01M | ﹤0.01% |
161,819
-98,804
| -38% | -$1.84M |
|
|
WWE
1038
DELISTED
World Wrestling Entertainment
WWE
| $3M | ﹤0.01% |
27,689
-14,173
| -34% | -$1.54M |
|
1039
FTI Consulting
FCN
$5.37B
| $3M | ﹤0.01% |
15,785
-4,671
| -23% | -$889K |
|
|
KRTX
1040
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3M | ﹤0.01% |
13,833
+1,008
| +8% | +$218K |
|
1041
Murphy USA
MUSA
$7.56B
| $2.99M | ﹤0.01% |
9,616
-517
| -5% | -$161K |
|
1042
M&T Bank
MTB
$30.8B
| $2.98M | ﹤0.01% |
24,097
-3,014
| -11% | -$373K |
|
1043
CarGurus
CARG
$3.58B
| $2.98M | ﹤0.01% |
131,509
+27,991
| +27% | +$633K |
|
1044
International Flavors & Fragrances
IFF
$16.9B
| $2.97M | ﹤0.01% |
37,351
-11,511
| -24% | -$916K |
|
1045
MYR Group
MYRG
$2.76B
| $2.96M | ﹤0.01% |
21,381
+8,362
| +64% | +$1.16M |
|
1046
Cross Country Healthcare
CCRN
$411M
| $2.94M | ﹤0.01% |
104,573
+22,106
| +27% | +$621K |
|
1047
Hexcel
HXL
$4.95B
| $2.93M | ﹤0.01% |
38,554
-44
| -0.1% | -$3.35K |
|
1048
Ciena
CIEN
$18.6B
| $2.93M | ﹤0.01% |
68,964
-462,334
| -87% | -$19.6M |
|
1049
Ameren
AEE
$27.2B
| $2.93M | ﹤0.01% |
35,813
-1,562
| -4% | -$128K |
|
1050
Datadog
DDOG
$48.4B
| $2.92M | ﹤0.01% |
29,714
-2,174
| -7% | -$214K |
|